CervoMed (CRVO) Enterprise Value (2022 - 2025)
Historic Enterprise Value for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$27.3 million.
- CervoMed's Enterprise Value rose 6034.9% to -$27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.3 million, marking a year-over-year increase of 6034.9%. This contributed to the annual value of -$38.9 million for FY2024, which is 39945.83% down from last year.
- Latest data reveals that CervoMed reported Enterprise Value of -$27.3 million as of Q3 2025, which was up 6034.9% from -$33.5 million recorded in Q2 2025.
- Over the past 5 years, CervoMed's Enterprise Value peaked at -$6.4 million during Q1 2024, and registered a low of -$68.8 million during Q3 2024.
- In the last 4 years, CervoMed's Enterprise Value had a median value of -$27.3 million in 2025 and averaged -$27.3 million.
- Examining YoY changes over the last 5 years, CervoMed's Enterprise Value showed a top increase of 6388.82% in 2024 and a maximum decrease of 56031.56% in 2024.
- Quarter analysis of 4 years shows CervoMed's Enterprise Value stood at -$16.5 million in 2022, then soared by 52.78% to -$7.8 million in 2023, then plummeted by 399.46% to -$38.9 million in 2024, then grew by 29.87% to -$27.3 million in 2025.
- Its Enterprise Value stands at -$27.3 million for Q3 2025, versus -$33.5 million for Q2 2025 and -$35.2 million for Q1 2025.